PSILOCYBIN FOR MAJOR DEPRESSION GRANTED BREAKTHROUGH THERAPY BY FDAPOSTED ON JULY 29, 2022The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).Back in late 2